11Nov
COVID-19 Report for Life Sciences and Health Care Companies (UPDATED)
In Tuesday's Report: the expanding role of real-world evidence in FDA medical device submissions; President-elect Joe Biden lays out COVID-19 plan; Pfizer announces vaccine efficacy; and an analysis of material adverse change (MAC) clauses in Japan....
By:
Hogan Lovells
Related
Goldman Sachs is reportedly in negotiations with federal prosecutors to resolve claims about its rol...
Read More >
As we previously reported, Connecticut has enacted the Time’s Up Act (the “Act”), which expanded ...
Read More >
Governor Mills has signed into law amendments to the existing Workers’ Compensation Act that are th...
Read More >
Our International Arbitration & Dispute Resolution Team explores an Eleventh Circuit ruling in a cas...
Read More >
A report by Cerulli on the future of the retirement plan business had a startling number. The report...
Read More >
In an effort to align its legislation with the broader standards of the New York City Human Rights L...
Read More >